Revenue: Not disclosed in the provided data (revenue field null). Gross profit: -$331.00; Gross profit margin: not calculable from the data; YoY gross profit change: +28.04%; QoQ gross profit change: +0.00%.
Operating income: -$218,806.00; YoY operating income change: +70.09%; QoQ change: +58.96%.
Net income: -$9,688,834.00; YoY change: -1321.05%; QoQ change: -1700.41%.
EPS (diluted): -$0.18; YoY EPS change: -1150.00%; QoQ EPS change: -1700.00%.
EBITDA: -$9,678,859.00; EBITDARatio: not provided.
Cash flow: Net cash provided by operating activities: -$94,017.00; Net cash used in investing activities: -$178,506.00; Free cash flow: -$273,496.00; Net change in cash: $2,477.00; Cash at end of period: $52,212.00.
Balance sheet highlights (selected):
- Total assets: $112,252
- Total current assets: $74,935
- Cash and cash equivalents: $52,212; Short-term investments: $6,000; Total current liabilities: $5,757,613; Long-term debt: $125,567; Total debt: $2,289,306; Net debt: $2,237,094
- Retained earnings: -$138,927,778; Accumulated OCI: -$504,650; Total stockholders’ equity: -$5,808,501; Other stockholders’ equity: $133,623,927.
Notes: The balance sheet presents notable inconsistencies (e.g., total assets far smaller than total liabilities; substantial positive “othertotalStockholdersEquity” amid a negative total stockholders’ equity), suggesting potential data quality issues or unusual accounting classifications in the provided figures. Investors should treat the liquidity and equity position as highly fragile absent corroborating, reconciled disclosures.